| TTM
|
7/31/2026
|
7/31/2025
|
7/31/2024
|
7/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
82,509.4100 | 82,509.4100 | 90,370.7930 | 68,424.5770 | 62,944.0730 |
|
Cost of Revenue
|
-28,471.1790 | -28,471.1790 | -22,040.0540 | -16,211.7790 | -17,049.1670 |
|
Gross Profit
|
54,038.2310 | 54,038.2310 | 68,330.7390 | 52,212.7980 | 45,894.9060 |
| Selling, General and Administrative Expenses
|
-57,556.5190 | -57,556.5190 | -63,867.1300 | -44,604.0760 | -37,393.1380 |
|
Research and Development Expenses
|
-3,805.4470 | -3,805.4470 | -5,528.7330 | -952.4400 | -2,913.4360 |
|
Operating Income/Expenses
|
-61,361.9660 | -61,361.9660 | -69,395.8630 | -45,556.5160 | -40,306.5740 |
|
Total Operating Profit/Loss
|
-7,323.7350 | -7,323.7350 | -1,065.1240 | 6,656.2820 | 5,588.3320 |
| Total Net Finance Income/Expense
|
540.9330 | 540.9330 | 494.3580 | 300.9850 | 41.0350 |
| Net Investment Income
|
293.7640 | 293.7640 | -287.9460 | 784.6740 | -566.1000 |
| Irregular Income/Expenses
|
238.5610 | 238.5610 | 4,709.0290 | 0 | 0 |
|
Other Income/Expense, Non-Operating
|
424.6380 | 424.6380 | 555.0120 | 454.2860 | 173.2910 |
|
Non-Operating Income/Expenses, Total
|
1,497.8960 | 1,497.8960 | 5,470.4530 | 1,539.9450 | -351.7740 |
|
Pretax Income
|
-5,825.8390 | -5,825.8390 | 4,405.3290 | 8,196.2270 | 5,236.5580 |
|
Provision for Income Tax
|
1,694.1710 | 1,694.1710 | -576.7660 | -2,218.5880 | -1,838.1740 |
|
Net Income from Continuing Operations
|
-4,131.6680 | -4,131.6680 | 3,828.5630 | 5,977.6390 | 3,398.3840 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-4,131.6680 | -4,131.6680 | 3,828.5630 | 5,977.6390 | 3,398.3840 |
|
Net Income after Non-Controlling/Minority Interests
|
-4,131.6680 | -4,131.6680 | 3,828.5630 | 5,977.6390 | 3,398.3840 |
|
Net Income Available to Common Stockholders
|
-4,131.6680 | -4,131.6680 | 3,828.5630 | 5,977.6390 | 3,398.3840 |
|
Diluted Net Income Available to Common Stockholders
|
-4,131.6680 | -4,131.6680 | 3,828.5630 | 5,977.6390 | 3,398.3840 |
| Basic EPS
|
-0.07 | -0.07 | 0.06 | 0.10 | 0.05 |
| Diluted EPS
|
-0.07 | -0.07 | 0.06 | 0.10 | 0.05 |
|
Basic Weighted Average Shares Outstanding
|
62,418.3820 | 62,418.3820 | 62,400 | 62,400 | 62,400 |
|
Diluted Weighted Average Shares Outstanding
|
62,418.3820 | 62,418.3820 | 62,400 | 62,400 | 62,400 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-6,366.7720 | -6,366.7720 | 3,910.9710 | 7,895.2420 | 5,195.5230 |
|
EBITDA
|
-5,934.0380 | -5,934.0380 | 4,320.9830 | 8,413.2990 | 7,344.0790 |
|
Normalized EBITDA
|
3,467.0760 | 3,467.0760 | 7,960.9680 | 11,999.2320 | 10.6340 |
|
Normalized Income
|
-1,340.5171 | -1,340.5171 | 146.4183 | 5,748.0218 | 5,533.2851 |
|
Total Unusual Items
|
3,935.6330 | 3,935.6330 | -4,236.7330 | -314.8460 | 3,289.5240 |
|
Total Unusual Items Excluding Goodwill
|
3,935.6330 | 3,935.6330 | -4,236.7330 | -314.8460 | 3,289.5240 |
7/31/2023 - 8/6/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade